Peptides studied for modulating the inflammatory response, often via NF-kB and cytokine signalling.
Lowers pro-inflammatory signalling and oxidative stress via nitric-oxide modulation.
Suppresses NF-kB nuclear translocation and downstream cytokines across cell models.
Calibrates immune tolerance via IDO/Treg pathways, studied for dampening harmful inflammation.
Lowering mitochondrial ROS reduces the oxidative stress that drives inflammatory signalling in preclinical models.
Modulates inflammatory signalling during the repair phase of healing.
Modulates TLR signalling with context-dependent pro- or anti-inflammatory effects.
Reduces antigen-driven mucosal immune activation by restoring barrier integrity.
Reduces inflammatory mediators (e.g. TNF) and oxidative damage in wound models.
⚠️ Educational research information only — not medical advice. Many peptides are research-use-only and not approved treatments. Always consult a qualified professional.